drugset / Trial / NCT00954681
Study of Quetiapine Treatment for Cannabis Dependence
Phase 2
Completed
15 enrolled
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA) · collab
NaSingle-groupOpen-labelTreatment
Summary
Marijuana is the most commonly used illicit drug in the United States. However, the treatment options for cannabis dependence are limited; notably, no effective pharmacotherapy has been developed. Conceptually, the ideal medication treatment for cannabis dependence would: 1. be safe when administered to patients actively using cannabis 2. reduce cannabis intake and promote abstinence 3. treat the symptoms of cannabis withdrawal 4. reduce craving and relapse risk 5. have a low abuse liability.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 300 mg | — |